DRSLTR 1 filename1.htm DRSLTR
  

505 Montgomery Street, Suite 2000

San Francisco, California 94111-6538

Tel: +1.415.391.0600    Fax: +1.415.395.8095

www.lw.com

 

FIRM / AFFILIATE OFFICES

LOGO

 

August 20, 2021

  

Beijing

Boston

Brussels

Century City                

Chicago

Dubai

Düsseldorf

Frankfurt

Hamburg

Hong Kong

Houston

London

Los Angeles

Madrid

Milan

  

Moscow

Munich

New York

Orange County

Paris

Riyadh

San Diego

San Francisco

Seoul

Shanghai

Silicon Valley

Singapore

Tokyo

Washington, D.C.                

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Manufacturing

100 F Street, N.E.

Washington, D.C. 20549-6010

 

Attention:

Mindy Hooker

    

John Cash

    

Asia Timmons-Pierce

    

Jay Ingram

 

  Re:

Arteris, Inc.

      

Amendment No. 1 to

      

Draft Registration Statement on Form S-1

      

Submitted July 26, 2021

      

CIK No. 0001667011

Ladies and Gentlemen:

Arteris, Inc. (the “Company”) has submitted to the U.S. Securities and Exchange Commission (the “Commission”) on the date hereof a revised draft Registration Statement on Form S-1 (the “Amendment No. 2”). The Company previously submitted to the Commission on June 11, 2021 a draft Registration Statement on Form S-1 on a confidential basis pursuant to Title I, Section 106 under the Jumpstart Our Business Startups Act, as amended by Amendment No. 1 of the draft Registration Statement (“Amendment No. 1”) submitted on July 26, 2021. Amendment No. 2 has been revised to reflect the Company’s response to the comment letter to Amendment No. 1 received on August 9, 2021 from the staff of the Commission (the “Staff”), and we are hereby providing the Company’s response to the Staff’s letter.


August 20, 2021

Page 2

 

LOGO

 

For ease of review, we have set forth below the numbered comment of the Staff’s letter in bold type followed by the Company’s response thereto.

We will lose sales if we are unable to obtain government authorization to export certain of our products, page 38

 

1.

We note your response to prior comment 3. Please revise your disclosures to reflect the potential consequences reflected in the second paragraph of your response.

Response: The Company respectfully acknowledges the Staff’s comment and has revised the disclosure on page 104 of the Amendment No. 2.

* * *


August 20, 2021

Page 3

 

LOGO

 

We hope the foregoing answers are responsive to your comments. Please do not hesitate to contact me by telephone at (415) 395-8216 or by fax at (650) 463-2600 with any questions or comments regarding this correspondence.

Very truly yours,

/s/ Phillip Stoup

Phillip Stoup, Esq.

of LATHAM & WATKINS LLP

 

cc:

K. Charles Janac, Arteris, Inc.

    

Paul L. Alpern, Esq., Arteris, Inc.

    

Jack Sheridan, Esq., Latham & Watkins LLP

    

Page Mailliard, Esq., Latham & Watkins LLP

    

Eric Jensen, Esq., Cooley LLP

    

Seth Gottlieb, Esq., Cooley LLP

    

Richard Segal, Esq., Cooley LLP